Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Researchers identify circulating proteins associated with progression of diabetic kidney disease

Researchers identify circulating proteins associated with progression of diabetic kidney disease

In a breakthrough study published today in Nature Medicine, researchers at Joslin Diabetes Center have identified a group of 17 circulating inflammatory proteins that are consistently associated with the development and progression of diabetic kidney disease. These 17 proteins, called the Kidney Risk Inflammatory Signature (KRIS), could allow doctors to determine the risk of progression to end stage renal disease in a patient with diabetic kidney disease.

The researchers used data from 219 type 1 and 144 type 2 diabetes patients with kidney disease who had been monitored for the past 7-15 years by the Joslin Kidney Study. To see if their findings held true in different groups of people, they also included data and specimens from a cohort of 162 Pima Indians with type 2 diabetes, who had been similarly followed over a period of 10 to 15 years.

“The finding is amazing,” says Andrzej Krolewski, MD, PhD, head of the section on Genetics & Epidemiology at Joslin and Professor of Medicine at Harvard Medical School, senior author on the paper. “It looks like inflammatory processes the underlie progression to end stage renal disease are similar across two diabetes types and differing race backgrounds. The disease process is very homogenous.” This finding runs against the assumption that diabetic kidney disease might be heterogeneous disease process.

This proteomic study looked at each of the nearly 200 circulating inflammatory proteins using an innovative SOMAscan platform. Researchers recognized that the same 17 proteins played a role in the progression of diabetic kidney disease to end stage renal disease in all study cohorts. Patients with elevated KRIS proteins had a higher likelihood of disease progression.

“It was a comprehensive and unbiased evaluation on the role of almost all the known circulating inflammatory proteins, in contrary to what was done before where people were looking at a few candidate proteins,” says Monika Niewczas, MD, PhD, MPH, Assistant Investigator at Joslin and Assistant Professor of Medicine at Harvard Medical School, first author on the paper and the recipient of the JDRF Career Development Award. “What we found was that there are very specific components of inflammation that are key drivers of the process, and this concept may have not been appreciated before.”

The KRIS proteins include members of the Tumor Necrosis Factor Receptor, or TNF receptor family. Previous studies by these authors had pointed to the role of two TNF receptor proteins in kidney disease inflammation, but this study identified enrichment for the entire family of these proteins.

“We are confirming the previous findings about the TNF receptors, but this time we are not saying that this is one TNF or two TNF receptors,” says Dr. Krolewski. “There are six or seven, so the process is much more complex than everybody imagined. The other inflammatory proteins which are described in this manuscript are almost completely new. Nobody has talked about them before.”

Unexpectedly, the KRIS proteins did not originate in the kidney. This suggests there are some other processes occurring in disease progression that involve systemic inflammation.

The research team also determined that while the causes of both diabetic eye disease and diabetic kidney disease can be traced to inflammation, these KRIS proteins were not linked to the diabetic eye disease.

“These exciting findings broaden our understanding of how circulating inflammatory proteins contribute to diabetic kidney disease and highlight their importance as drug targets,” explains Marlon Pragnell, JDRF Sr. Program Scientist -Treat Therapeutics, Research. “As these proteins circulate throughout the body, it’s intriguing to speculate that drugs targeting these in people with diabetes might also benefit other organs in addition to the kidney”

A follow-up mechanistic study is planned to help the researchers understand exactly what each protein does in the inflammatory process. Once these mechanisms are uncovered, the KRIS proteins could be therapeutic targets for drug developers.

Taken together, the findings reported in this paper suggest a new way to think about the progression of kidney disease. “Our study has great potential to re-direct etiological studies on kidney complications in diabetes. Further exploration into the mechanisms could open up a whole new field of study” says Dr. Niewczas. We hope that this will help to identify new therapies to prevent and treat diabetic kidney disease, one of the major causes of the development of ESRD in the US.

Source:

https://www.joslin.org/news/new-novel-circulating-proteins-involved-in-progression-of-diabetic-kidney-disease-to-end-stage-renal-failure.html

Tagged with:

About author

Related Articles